肝细胞癌:临床试验需要注意
David Hsiehchen1, Amit G Singal1
1Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390-8887, USA.
Med (New York, N.Y.)
|March 14, 2026
概括
目前正在进行的临床试验正在探索查和治疗肝细胞癌 (HCC) 的新方法. 这些研究旨在改善HCC患者的早期检测和生存率.
科学领域:
- 肝胆药是一种肝胆药.
- 在瘤学瘤学.
- 翻译研究是翻译研究.
背景情况:
- 肝细胞癌 (HCC) 仍然是一个重大的全球健康挑战.
- 目前对HCC的管理策略需要优化,以改善患者的治疗结果.
- 查和治疗方面的进步有可能改变HCC护理.
研究的目的:
- 总结正在进行的肝细胞癌 (HCC) 查和治疗的临床试验.
- 突出提升HCC早期检测方法的进展.
- 审查包括免疫检查点抑制剂在内的HCC不断变化的治疗场景.
主要方法:
- 对HCC目前和即将进行的临床试验的审查.
- 对比新的查策略 (成像,基于血液) 与标准超声波.
- 对研究免疫检查点抑制剂和各种HCC阶段的新疗法的治疗试验的分析.
主要成果:
- 新型成像和基于血液的生物标志物正在评估早期HCC检测,旨在优于腹部超声波.
- 免疫检查点抑制剂显示出希望,并正在HCC早期,中期和晚期阶段进行测试.
- 新的治疗方案正在调查中,以提高HCC全谱的存活率.
结论:
- 目前正在进行的试验具有重大潜力,可以彻底改变肝细胞癌的治疗方法.
- 预计查和免疫治疗方面的进步将改善早期诊断和患者的存活率.
- 对于HCC的治疗环境正在迅速发展,为所有疾病阶段的患者提供了新的希望.
更多相关视频
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
9.6K
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
1.4K
相关概念视频
Clinical Trials
11.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
11.1K
Clinical Trials: Overview
5.3K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.3K
